Can doctors prescribe peptides in Australia?
Short answer: Yes. An AHPRA-registered doctor can lawfully prescribe unapproved peptides through the TGA Special Access Scheme Category B, or under the Authorised Prescriber scheme, with a TGA-licensed Australian compounding pharmacy dispensing. Most GPs decline simply because they don't work with these pathways — not because prescribing is prohibited.
Patients are often told 'peptides can't be prescribed in Australia'. That's wrong. What's true is that the products are unapproved, so prescribing runs through specific TGA pathways. Here's how those pathways work and what a compliant prescription looks like.
Key points
- Unapproved ≠ prohibited: SAS-B and Authorised Prescriber are lawful supply routes.
- Any AHPRA-registered doctor may use SAS-B; most simply choose not to.
- There is no TGA fee for SAS-B, and no Medicare rebate for the peptide.
- A compliant script names the doctor, the pathway and an Australian licensed pharmacy.
- Typical timeline: $99 consult, then script in 24–48 hours if appropriate.
The short legal answer
Almost no therapeutic peptide is registered on the ARTG, which stops it being advertised or sold to the public — but it does not stop a doctor prescribing it. Australian law creates exception pathways precisely for this situation: SAS Category B for a named patient, and the Authorised Prescriber scheme for a defined patient class. A doctor using either pathway is prescribing lawfully.
Why most GPs still say no
Three practical reasons: the SAS-B submission is unbilled administrative work, the published evidence for peptides like BPC-157 or CJC-1295 is thin compared with registered medicines, and dosing compounded products sits outside routine general practice. None of that makes prescribing improper — it just means the doctors who do it tend to be the ones who have built the process into their practice.
What the doctor must be satisfied of before prescribing
That a registered alternative is unsuitable or has been tried, that the expected benefit is reasonable for your indication, that your history — malignancy, cardiac, kidney and liver function, pregnancy, current medicines — does not contraindicate it, and that you understand the evidence is limited. These are the same obligations that apply to any prescription, applied to an unapproved product.
Where the pharmacy fits
The prescription goes to a TGA-licensed Australian compounding pharmacy, which prepares the vial to the doctor's specification with a known concentration, sterility control and cold-chain handling. This is the step that separates a lawful supply from a grey-market vial: someone accountable made the product to a standard.
What patients should ask for in writing
The prescribing doctor's name and AHPRA registration number, confirmation that SAS-B has been lodged or Authorised Prescriber approval applies, the name of the dispensing pharmacy, and the exact peptide, strength and dosing schedule. A provider unwilling to put those in writing is not operating the pathway properly.
SAS-B vs Authorised Prescriber vs no pathway
| TGA SAS-B | Authorised Prescriber | Online 'research' vial | |
|---|---|---|---|
| Lawful for personal use | Yes | Yes | No |
| Doctor assessment | Required | Required | None |
| TGA notification | Per patient, per product | Approval up front, periodic reporting | None |
| Dispensed by | Licensed Australian pharmacy | Licensed Australian pharmacy | Unregulated seller |
| Purity and sterility verified | Yes | Yes | No |
| Typical time to supply | 24–48 hours to script | Same or next day | Border seizure risk |
FAQs
- Can doctors prescribe peptides in Australia?
- Yes. An AHPRA-registered medical practitioner can lawfully prescribe an unapproved peptide for a named patient using the TGA Special Access Scheme Category B, or under the Authorised Prescriber scheme if they hold approval for that product and patient class. A TGA-licensed Australian compounding pharmacy then dispenses it.
- Do all doctors prescribe peptides?
- No. There is no rule stopping a GP from prescribing, but most decline because SAS-B involves extra paperwork, the evidence base for many peptides is limited, and they may not be familiar with compounded dosing. That is why patients usually see a doctor who works with these pathways regularly.
- What is the difference between SAS-B and Authorised Prescriber?
- SAS Category B is a per-patient notification the doctor submits to the TGA before supply. Authorised Prescriber approval lets a doctor supply a specified unapproved product to a defined class of patients without lodging each case individually. Both are lawful routes; SAS-B is the more common one.
- Does a peptide prescription need TGA approval every time?
- Under SAS-B, yes — a submission is made for each patient and product. There is no TGA fee. Under Authorised Prescriber, the approval is granted up front and the doctor reports supply periodically instead.
- Can a GP refuse to prescribe peptides?
- Yes. Prescribing is always a clinical judgement. A doctor can decline if the evidence does not support your indication, if your history raises risk, or if they are not comfortable with the pathway. A second opinion from a doctor experienced in SAS-B prescribing is reasonable.
- How long does it take to get a peptide prescription?
- For a straightforward case, the consult happens the same or next day and the SAS-B submission plus script is typically issued within 24 to 48 hours. Pharmacy compounding and delivery usually add a few business days.
- What does it cost to see a doctor about peptides?
- A $99 AUD telehealth consult with an AHPRA-registered doctor, plus the compounded peptide from the pharmacy, commonly $90 to $400 per vial depending on the peptide and strength. Medicare does not rebate unapproved peptides.
Related reading
Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.
Start lawfully — $99 telehealth consult
Free 5-minute pre-qualification. If suitable, you'll be matched with an AHPRA-registered Australian doctor — TGA SAS-B prescribing, Australian-compounded vial.
Start free assessment